FHA
TGTX icon

First Horizon Advisors’s TG Therapeutics TGTX Stock Holding History

First Horizon Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35
Closed -$1.38K – 2504
2025
Q1 		$1.38K Hold
35
– – ﹤0.01% 2071
2024
Q4 		$1.05K Hold
35
– – ﹤0.01% 2091
2024
Q3 		$818 Hold
35
– – ﹤0.01% 2165
2024
Q2 		$622 Hold
35
– – ﹤0.01% 2180
2024
Q1 		$532 Hold
35
– – ﹤0.01% 2216
2023
Q4 		$597 Hold
35
– – ﹤0.01% 2285
2023
Q3 		$292 Sell
35
-37
-51% -$516 ﹤0.01% 2342
2023
Q2 		$1.79K Hold
72
– – ﹤0.01% 2113
2023
Q1 		$1.08K Buy
+72
New +$1.09K ﹤0.01% 2249

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Horizon Advisors's TGTX Position: Q2 2025 in Review

First Horizon Advisors sold out of TG Therapeutics (TGTX) in Q2 2025, closing a stake of 35 shares — an estimated $1.38K sold.

First Horizon Advisors first reported a position in TGTX in Q1 2023 and held it in 9 quarters. The position peaked at $1.79K in Q2 2023. 356 funds tracked by Wall St. Rank hold TGTX as of Q2 2025.

  • First Horizon Advisors reported no remaining TG Therapeutics position as of Q2 2025 after selling out during the quarter.
  • First Horizon Advisors sold 35 TG Therapeutics shares in Q2 2025, an estimated $1.38K.
  • First Horizon Advisors first reported a position in TG Therapeutics in Q1 2023 and held it in 9 quarters.
  • First Horizon Advisors's TG Therapeutics position peaked at $1.79K in Q2 2023.
  • 356 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.